Perspectives on Therapies for Parkinson's Disease: Investigating Neuroprotectors and Progression Modifiers
Vol. 6 No. 2 (2024), Literature Review
Vol. 6 No. 2 (2024)

Perspectives on Therapies for Parkinson's Disease: Investigating Neuroprotectors and Progression Modifiers

Literature Review
https://doi.org/10.36557/2674-8169.2024v6n2p633-639
Published 2024-02-06
José Lucas Moura Vasconcelos
UniFG Guanambi
Andressa Karoline Alves Leite
UNIFAMAZ
https://orcid.org/0009-0000-1198-8622
Anisia da Silva Teixeira
UNIFACS
https://orcid.org/0009-0003-6119-3264
Bárbara Dayann Rocha Barreto
UNIFACS
https://orcid.org/0009-0005-1823-2613
Carla Maria Zanelli Pinaty
Universidade de Cuiabá - UNIC
https://orcid.org/0009-0002-9480-0537
Caroline Fernanda Alexandre Henrique
Universidade de Cuiabá - UNIC
https://orcid.org/0009-0003-0772-3690
Dhemer Jhony Dall'Agnol
Universidade de Cuiabá - UNIC
https://orcid.org/0009-0000-4531-8029
Giovanna Vieira Brito
Universidade de Cuiabá - UNIC
https://orcid.org/0009-0004-8754-666X
Giovana Pereira Viana
UNIFG Guanambi
https://orcid.org/0009-0009-6870-2862
Heloísa Maria Marson Bonatti
Universidade do Oeste Paulista - UNOESTE
https://orcid.org/0009-0005-5035-3538
Julia Maria Prestes Capatto
Universidade de Cuiabá - UNIC
https://orcid.org/0009-0003-8055-7086
Kauara Marcelino Gonçalves
Universidade de Cuiabá - UNIC
https://orcid.org/0009-0000-2383-8744
Larissa Cunha Hipolito Rodrigues
UNIFACS
https://orcid.org/0009-0005-8841-3137
Luana Cruz Nunes Godinho
Universidade de Cuiabá - UNIC
https://orcid.org/0009-0000-3258-5849
Maria Eugênia Abílio Lima
Centro Universitário FipMoc - UnifipMoc
https://orcid.org/0009-0007-7982-7252
Maria Fernanda Monteiro Costa
Universidade de Cuiabá - UNIC
https://orcid.org/0009-0003-8928-5507
Mariana Horn da Cruz
UniFOA
https://orcid.org/0009-0005-8803-5308
Radhija Albuquerque Rocha Cardoso
UNIFG Brumado
https://orcid.org/0009-0008-6785-0081
Renata Gomes Santos Guimarães
UNIFACS
https://orcid.org/0009-0003-7887-5034
Samuel Antunes Correia Bomfim
UNIFG Guanambi
https://orcid.org/0009-0001-3385-7997
Thiago Matheus Ribeiro Da Silva
Universidade de Cuiabá - UNIC
https://orcid.org/0009-0001-9854-5767
PDF (Português (Brasil))

Keywords

Parkinson's disease

How to Cite

Vasconcelos, J. L. M., Leite , A. K. A., Teixeira, A. da S., Barreto , B. D. R., Pinaty , C. M. Z., Henrique , C. F. A., Dall’Agnol, D. J., Brito , G. V., Viana , G. P., Bonatti , H. M. M., Capatto , J. M. P., Gonçalves , K. M., Rodrigues , L. C. H., Godinho , L. C. N., Lima , M. E. A., Costa , M. F. M., Cruz , M. H. da, Cardoso , R. A. R., Guimarães , R. G. S., Bomfim, S. A. C., & Silva , T. M. R. D. (2024). Perspectives on Therapies for Parkinson’s Disease: Investigating Neuroprotectors and Progression Modifiers. Brazilian Journal of Implantology and Health Sciences, 6(2), 633–639. https://doi.org/10.36557/2674-8169.2024v6n2p633-639
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

This review addressed advances in the development of neuroprotective and progression-modifying therapies in Parkinson's disease (PD). Literature analysis highlighted the potential of therapeutic strategies based on antioxidants, gene therapy, and other innovative approaches to slow down PD progression. The results of reviewed studies suggest that these therapies show significant promise in reducing motor symptoms and preserving dopaminergic function. However, challenges such as PD heterogeneity and lack of robust biomarkers remain significant obstacles to translating these findings into effective therapies. Ongoing research and interdisciplinary collaboration are essential to drive innovation and transform these promising therapeutic perspectives into clinical reality.

https://doi.org/10.36557/2674-8169.2024v6n2p633-639
PDF (Português (Brasil))

References

Schapira, A. H., Olanow, C. W., Greenamyre, J. T., & Bezard, E. (2014). Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives. The Lancet, 384(9942), 545-555.

Jenner, P., & Olanow, C. W. (2006). Understanding cell death in Parkinson's disease. Annals of Neurology, 59(3), 421-429.

Kalia, L. V., & Lang, A. E. (2015). Parkinson's disease. The Lancet, 386(9996), 896-912.

Ascherio, A., Zhang, S. M., Hernán, M. A., Kawachi, I., Colditz, G. A., Speizer, F. E., & Willett, W. C. (2001). Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Annals of Neurology, 50(1), 56-63.

Chen, H., Zhang, S. M., Hernán, M. A., Willett, W. C., Ascherio, A., & F. E. (2002). Diet and Parkinson's disease: a potential role of dairy products in men. Annals of Neurology, 52(6), 793-801.

Olanow, C. W., & Schapira, A. H. (2013). Therapeutic prospects for Parkinson disease. Annals of Neurology, 74(3), 337-347.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2024 José Lucas Moura Vasconcelos, Andressa Karoline Alves Leite , Anisia da Silva Teixeira, Bárbara Dayann Rocha Barreto , Carla Maria Zanelli Pinaty , Caroline Fernanda Alexandre Henrique , Dhemer Jhony Dall'Agnol, Giovanna Vieira Brito , Giovana Pereira Viana , Heloísa Maria Marson Bonatti , Julia Maria Prestes Capatto , Kauara Marcelino Gonçalves , Larissa Cunha Hipolito Rodrigues , Luana Cruz Nunes Godinho , Maria Eugênia Abílio Lima , Maria Fernanda Monteiro Costa , Mariana Horn da Cruz , Radhija Albuquerque Rocha Cardoso , Renata Gomes Santos Guimarães , Samuel Antunes Correia Bomfim, Thiago Matheus Ribeiro Da Silva